U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07402109) titled 'CBCT Guided Markerless SBRT for Renal Cell Cancer' on Sept. 30, 2025.
Brief Summary: This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Renal Cell Carcinoma (RCC)
Intervention:
RADIATION: Additional radiation due to imaging
Additional imaging will be done using CT, therefore the patient will receive additional radiation dose
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Erasmus Medical Center
Information provided by (Re...